20 June 2013
Keywords: genvac, gets, fda, fast, track, tnferade, drug
Article | 17 November 2008
US drug developer GenVec has been granted Fast Track designation for TNFerade for the treatment of locally-advanced pancreatic cancer by ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 November 2008
19 June 2013
© 2013 thepharmaletter.com